128 related articles for article (PubMed ID: 25766669)
21. Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
Uyar D; Neary J; Monroe A; Nugent M; Simpson P; Geurts JL
Gynecol Oncol; 2018 Jun; 149(3):565-569. PubMed ID: 29653687
[TBL] [Abstract][Full Text] [Related]
22. Adherence to the National Institute of Clinical Excellence guidance on parenteral nutrition screening is not enough to improve outcomes.
Vincent RP; Omar S; Elnenaei MO; Goo CH; Salota R; Wu P; Delaney HL; le Roux CW
Clin Nutr; 2013 Feb; 32(1):73-6. PubMed ID: 22687466
[TBL] [Abstract][Full Text] [Related]
23. Future cancer risk after urgent suspected cancer referral in England when cancer is not found: a national cohort study.
Scott SE; Gildea C; Nicholson BD; Evans RE; Waller J; Smith D; Purushotham A; Round T
Lancet Oncol; 2023 Nov; 24(11):1242-1251. PubMed ID: 37922929
[TBL] [Abstract][Full Text] [Related]
24. The generally low sensitivity of CA 125 for FIGO stage I ovarian cancer diagnosis increases for endometrioid histotype.
Grandi G; Perrone AM; Toss A; Vitagliano A; Friso S; Facchinetti F; Cortesi L; Cascinu S; De Iaco P
Minerva Med; 2020 Apr; 111(2):133-140. PubMed ID: 32338842
[TBL] [Abstract][Full Text] [Related]
25. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China.
Chen H; Qian L; Jiang M; Du Q; Yuan F; Feng W
Ultrasound Obstet Gynecol; 2019 Dec; 54(6):815-822. PubMed ID: 31152572
[TBL] [Abstract][Full Text] [Related]
26. A prospective audit of the implementation of the 2-week rule for assessment of suspected urological cancers.
Coxon JP; Harris HJ; Watkin NA
Ann R Coll Surg Engl; 2003 Sep; 85(5):347-50. PubMed ID: 14594541
[TBL] [Abstract][Full Text] [Related]
27. Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.
Barclay M; Gildea C; Poole J; Hirschowitz L; Menon U; Nordin A
Int J Gynecol Cancer; 2016 Jan; 26(1):56-65. PubMed ID: 26509852
[TBL] [Abstract][Full Text] [Related]
28. Ovarian cancer: risk factors, treatment and management.
Rooth C
Br J Nurs; 2013 Sep 12-25; 22(17):S23-30. PubMed ID: 24067270
[TBL] [Abstract][Full Text] [Related]
29. The two-week wait cancer initiative on oral cancer; the predictive value of urgent referrals to an oral medicine unit.
Singh P; Warnakulasuriya S
Br Dent J; 2006 Dec; 201(11):717-20; discussion 714. PubMed ID: 17159958
[TBL] [Abstract][Full Text] [Related]
30. 'Two week wait' standards for suspected gynaecological malignancy. On target, but missing the point?
Morrison J; Gillespie S; MacKenzie IZ
J Br Menopause Soc; 2003 Dec; 9(4):170-2. PubMed ID: 15107261
[TBL] [Abstract][Full Text] [Related]
31. Significance of adding progesterone to the Risk of Ovarian Malignancy Algorithm for early stage ovarian cancer detection in patients with a pelvic mass: A single-center case-control study.
Pitynski K; Sporek A; Lipinska I; Banas T; Ludwin A; Bałajewicz-Nowak M
Taiwan J Obstet Gynecol; 2015 Dec; 54(6):766-72. PubMed ID: 26701000
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
[TBL] [Abstract][Full Text] [Related]
33. Assessment of diagnostic utility of multivariate diagnostic models in differential diagnosis of ovarian tumors.
Horała A; Swiatly A; Lorek J; Kokot ZJ; Matysiak J; Nowak-Markwitz E
Ginekol Pol; 2018; 89(10):568-572. PubMed ID: 30393846
[TBL] [Abstract][Full Text] [Related]
34. Outcomes for patients referred urgently with suspected head and neck cancer.
Hobson JC; Malla JV; Sinha J; Kay NJ; Ramamurthy L
J Laryngol Otol; 2008 Nov; 122(11):1241-4. PubMed ID: 18371234
[TBL] [Abstract][Full Text] [Related]
35. Survival in ovarian cancer in Wales: Prior to introduction of all Wales guidelines.
Shylasree TS; Howells RE; Lim K; Jones PW; Fiander A; Adams M; Evans AS;
Int J Gynecol Cancer; 2006; 16(5):1770-6. PubMed ID: 17009970
[TBL] [Abstract][Full Text] [Related]
36. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP).
Menon U; Weller D; Falborg AZ; Jensen H; Butler J; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Fourkala EO; Gavin AT; Grunfeld E; Harland E; Kalsi J; Law RJ; Lin Y; Turner D; Neal RD; White V; Harrison S; Reguilon I; Lynch C; Vedsted P;
Br J Cancer; 2022 Sep; 127(5):844-854. PubMed ID: 35618787
[TBL] [Abstract][Full Text] [Related]
38. Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis.
Swanson CL; Kumar A; Maharaj JM; Kemppainen JL; Thomas BC; Weinhold MR; Slaby KM; Mara KC; Wick MJ; Bakkum-Gamez JN
Gynecol Oncol; 2018 Apr; 149(1):121-126. PubMed ID: 29402500
[TBL] [Abstract][Full Text] [Related]
39. Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.
Miller RW; Smith A; DeSimone CP; Seamon L; Goodrich S; Podzielinski I; Sokoll L; van Nagell JR; Zhang Z; Ueland FR
Obstet Gynecol; 2011 Jun; 117(6):1298-1306. PubMed ID: 21555961
[TBL] [Abstract][Full Text] [Related]
40. Under utilisation of the 2-week wait initiative for lung cancer by primary care and its effect on the urgent referral pathway.
Lewis NR; Le Jeune I; Baldwin DR
Br J Cancer; 2005 Oct; 93(8):905-8. PubMed ID: 16189521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
